Evidence map›Paper›PMID 35835680›Full record

ReviewThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2022

Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support.

Manreet K Kanwar, Craig H Selzman, Van-Khue Ton, Oliver Miera, William K Cornwell, James Antaki, Stavros Drakos, Palak Shah

Abstract readReview
In one paragraph

Review in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Myocardial recovery in children supported with a durable ventricular assist device-a systematic review.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2023
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Manreet K KanwarCardiovascular Institute, Allegheny Health Network, Pittsburgh, Pennsylvania. Electronic address: manreet.kanwar@ahn.org.
Craig H SelzmanDivision of Cardiothoracic Surgery, University of Utah, Salt Lake City, Utah.
Van-Khue TonMassachusetts General Hospital, Harvard Medical School, Boston, Maryland.
Oliver MieraDepartment of Congenital Heart Disease, Pediatric Cardiology, German Heart Center, Berlin, Germany.
William K CornwellDepartment of Medicine Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
James AntakiMeinig School of Biomedical Engineering, Cornell University, Ithaca, New York.
Stavros DrakosDivision of Cardiovascular Medicine, University of Utah, Salt Lake City, Utah.
Palak ShahInova Heart and Vascular Institute, Falls Church, Virginia.

Funding

CORA_TM_A Personalized Cardiac Counselor for Optimal TherapyR01HL122639 · NHLBI · CORNELL UNIVERSITY · PI ANTAKI, JAMES F., MURALI, SRINIVAS · 2015 to 2018
$3.5M
MicroRNA Biomarkers of Allograft Rejection and Cardiac Allograft Vasculopathy in Cardiac TransplantationK23HL143179 · NHLBI · INOVA HEALTH CARE SERVICES · PI SHAH, PALAK · 2020 to 2024
$927k
AHRQ HHS R01 HS027784NHLBI NIH HHS K23 HL143179NHLBI NIH HHS R01 HL122639
6 · The paper itself

Abstract

Left ventricular assist-device (LVAD) implantation is a life-saving therapy for patients with advanced heart failure (HF). With chronic unloading and circulatory support, LVAD-supported hearts often show significant reverse remodeling at the structural, cellular and molecular level. However, translation of these changes into meaningful cardiac recovery allowing LVAD explant is lagging. Part of the reason for this discrepancy is lack of anticipation and hence promotion and evaluation for recovery post LVAD implant. There is additional uncertainty about the long-term course of HF following LVAD explant. In selected patients, however, guided by the etiology of HF, duration of disease and other clinical factors, significant functional improvement and LVAD explantation with long-term freedom from recurrent HF events has been demonstrated to be feasible in a reproducible manner. The identified predictors of myocardial recovery suggest that the elective therapeutic use of potentially less invasive VADs for reversal of HF earlier in the disease process is a future goal that warrants further investigation. Hence, it is prudent to develop and implement tools to predict HF reversibility prior to LVAD implant, optimize unloading-promoted recovery with guideline directed medical therapy and monitor for myocardial improvement. This review article summarizes the clinical aspects of myocardial recovery and together with its companion review article focused on the biological aspects of recovery, they aim to provide a useful framework for clinicians and investigators.

Indexed as

Heart-Assist DevicesHeart FailureHeartHumansMyocardiumRecovery of Functionclinical, remodelingGDMTLVADmyocardial recovery

Identifiers

PMID35835680
PMCPMC10257189

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.